Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review

Marie Lindhard Madsen(Aalborg University Hospital), Karen Dybkær(Aalborg University Hospital), Paw Jensen(Aalborg University Hospital), Niels Ejskjær(Steno Diabetes Centers), Hanne Due(Aalborg University Hospital), Jakob Madsen(Aalborg University Hospital)

Cancer Chemotherapy and Pharmacology

June 18, 2019

10.1007/s00280-019-03884-5

Cited by 127

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

|Journal of Diabetes Science and Technology|2022|288